Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2016

View Archived Issues

Two-antibody cocktail MIL77E protects primates from Ebola virus

NEOMED Institute announces partnership opportunities

EM Imaging and Mauna Kea enter clinical molecular imaging research collaboration

Researchers present novel murine models to study Zika virus

FDA grants orphan drug designation to ANAVEX 3-71 for frontotemporal dementia

Conference round-up: Biomarker studies from the USCAP Annual Meeting

MRC Technology and IPS-CAS enter antibody research agreement

FDA grants priority review to atezolizumab BLA in NSCLC

Bayer Schering Pharma discloses factor XIa kallikrein B inhibitors

Merck & Co. patents prolyl hydroxylase inhibitors

Shifa Biomedical reports endothelial lipase inhibitors

MedImmune reports antibodies linked to dimeric pyrrolobenzodiazepine

Helmsley Charitable Trust funds research into cell-based therapies for type 1 diabetes

Human Vaccines Project announces Mesa Consortium

Pritumumab receives FDA orphan drug designation for the treatment of pancreatic cancer

Somatostatin-dopamine chimeric compound demonstrates preclinical efficacy for acromegaly

Merck KGaA announces CE Mark approval for OncoBEAM RAS CRC test

FDA advisory committee set to review rociletinib NDA

MSD K.K. and Taiho sign copromotion agreement for pembrolizumab in Japan

Kyoto University and Sumitomo Dainippon Pharma launch second stage of DSK Project

4D pharma acquires Spanish company Instituto Biomar

FDA approves BromSite to prevent pain and treat inflammation following cataract surgery

EMA committee recommends that Alprolix maintains orphan drug designation

Addex Therapeutics announces results from dipraglurant clinical trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...